US Stock and Financial News

AstraZeneca’s Calquence Tablet Formulation Gets FDA Approval

By Anthony O. Goriainoff AstraZeneca PLC said Friday that its lymphoma treatment Calquence’s tablet formulation has been approved by the U.S. Food and Drug…

Related Articles

Back to top button